MoneyWorks4Me

Indoco Remedies informs about dividend updates

17 May 2022 Evaluate
Indoco Remedies has informed that the Board of Directors of the Company at its meeting held today i.e. 17-05-2022 has considered and approved the following: Subject to the approval of the Members at the ensuing 75th AGM, recommended a Dividend of Rs.2.25 per share (including a Special Dividend of Rs. 0.75) on face value of Rs. 2 for the Financial year 2021-2022.

The above information is a part of company’s filings submitted to BSE.


Indoco Remedies Share Price

221.60 -0.25 (-0.11%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: